BioNTech co-founder Ugur Sahin among world 500 richest people: Bloomberg
New Delhi: Ugur Sahin just reached another milestone. The co-founder of BioNTech SE on Thursday joined the world's 500 richest people after the UK this week approved use of a vaccine that the German firm created with Pfizer Inc.BioNTech's shares have jumped almost 8% this week and are up over 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1...
Login or Register to read the full article
New Delhi: Ugur Sahin just reached another milestone. The co-founder of BioNTech SE on Thursday joined the world's 500 richest people after the UK this week approved use of a vaccine that the German firm created with Pfizer Inc.
BioNTech's shares have jumped almost 8% this week and are up over 250% for the year. Sahin is now the 493rd-richest person on the planet with a net worth of $5.1 billion, according to Bloomberg Billionaires Index. Sahin didn't reply to a request for comment.
Turkish-born scientist Sahin is the sole shareholder of a German firm that controls an 18% stake in BioNTech, which raised $150 million from its US initial public offering last year, filings show. Sahin joins Germany's Struengmann brothers among the world's 500 richest. They own about half of BioNTech and their fortune is estimated at more than $24 billion combined.
The race to produce a Covid-19 vaccine has also lifted a group of investors at Moderna. Shares of the Massachusetts based firm have surged over 700% this year, making billionaires of some early investors, including MIT professor Bob Langer and Harvard professor Tim Springer, as well as CEO Stephane Bancel, who is now worth $4.9 billion.
Read also: UK poised to become first country to approve Pfizer vaccine: Bloomberg
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd